---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026815"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:49:47.804755+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical receives FDA 510(k) clearance for LIBERTY Endovascular Robotic System

## Summary
- FDA 510(k) clearance for LIBERTY System, first single-use remotely operated robotic system for peripheral endovascular procedures.
- Pivotal study showed 100% robotic navigation success and zero device-related adverse events; 92% relative reduction in physician radiation exposure.
- Plans to commence commercialization in Q4 2025; initial U.S. addressable market of ~2.5M peripheral vascular procedures annually.
- CEO Harel Gadot to present at H.C. Wainwright Annual Investor Conference on Sept 9, 2025 at 9 AM ET.

## SEC filing metadata
- accession: 0001641172-25-026815
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225026815/0001641172-25-026815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225026815/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026815
- JSON: https://secwatch.observer/filing/0001641172-25-026815.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.